Latest Ratings for PGNY Date Firm Action From To Dec 2021 Jefferies Initiates Coverage On Buy Sep 2021 Berenberg Initiates Coverage On Buy Sep 2021 Barclays Maintains Overweight View More Analyst Ratings for PGNY View the Latest Analyst Ratings read more
Latest Ratings for ANAB Date Firm Action From To Mar 2022 HC Wainwright & Co. Maintains Buy Jun 2021 HC Wainwright & Co. Initiates Coverage On Buy May 2021 UBS Initiates Coverage On Neutral View More Analyst Ratings for ANAB View the Latest Analyst Ratings read more
Latest Ratings for MQ Date Firm Action From To Mar 2022 JP Morgan Maintains Overweight Mar 2022 Truist Securities Maintains Buy Mar 2022 Keefe, Bruyette & Woods Maintains Market Perform View More Analyst Ratings for MQ View the Latest Analyst Ratings read more
Latest Ratings for HQY Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Dec 2021 JP Morgan Maintains Overweight Dec 2021 Deutsche Bank Maintains Buy View More Analyst Ratings for HQY View the Latest Analyst Ratings read more
Latest Ratings for GPN Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Rosenblatt Maintains Buy Feb 2022 Raymond James Maintains Outperform View More Analyst Ratings for GPN View the Latest Analyst Ratings read more
PTC Therapeutics partners with Novartis for its PTC518 Huntington’s program in a deal valued up to $2.9 billion, including milestones and royalties. read more
The success of Nvidia in recent years could have been much different if co-founder and CEO Jensen Huang took a job he was offered in 2013. read more